SALE
市場調查報告書

治療用血漿替換的全球市場 - 預測和機會:2025年

Global Therapeutic Plasma Exchange Market By Technique, By Indication, By Gender, By End Use, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 934763
出版日期 內容資訊 英文 112 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

治療用血漿替換的全球市場 - 預測和機會:2025年 Global Therapeutic Plasma Exchange Market By Technique, By Indication, By Gender, By End Use, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 112 Pages
簡介

全球治療用血漿替換市場,在預測期間內預計以活躍的速度成長。治療用血漿替換或血漿替換,是借助離心分離或膜分離技術從血液分離血漿,過濾血液,除去在血漿中有害的抗體的步驟。交換體內血液的流程的治療用血漿替換或血漿替換療法,隨著慢性疾病增加而見證需求大幅增加。譬如格林巴利症候群 (GBS) 等。據此,給予全球的血漿替換市場積極的影響。 但,血漿替換療法昂貴,有可能妨礙市場成長。

全球治療用血漿替換市場,市場區分為各技術、各適應症、性別、各最終用途、各地區。各適應症,再分為神經病變,腎障礙,血液疾病,代謝障礙,隨著慢性、致命的神經病變的病例數每天逐漸增加,神經病變成為最主要的市場區隔。

本報告提供全球治療用血漿替換市場相關調查分析,市場規模、佔有率、預測,各市場區隔分析,競爭分析,市場趨勢的變化,新興機會相關的系統性資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 客戶的迴響

第5章 全球治療用血漿替換市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 產品市場地圖

第6章 亞太地區的治療用血漿替換市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 亞太地區:各國分析

第7章 歐洲的治療用血漿替換市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 歐洲:各國分析

第8章 北美的治療用血漿替換市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 北美:各國分析

第9章 南美的治療用血漿替換市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 南美:各國分析

第10章 中東、非洲的治療用血漿替換市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 中東、非洲:各國分析

第11章 市場動態

  • 促進因素
  • 課題

第12章 市場趨勢與趨勢

第13章 競爭情形

第14章 策略性建議

第15章 出版社和免責聲明

目錄
Product Code: 4598

The global market for therapeutic plasma exchange is anticipated to grow at brisk rate during the forecast period. Therapeutic plasma exchange or plasmapheresis is a procedure to filter blood and remove harmful antibodies present in plasma by separating it from blood with the assistance of techniques called centrifugation or membrane separation. Therapeutic plasma exchange or Plasmapheresis, the process of replacing blood in the body, has witnessed significant rise in demand on account of increasing chronic diseases, for instance, Guillain Barre Syndrome (GBS); thereby, positively influencing the therapeutic plasma exchange market across the globe. However, plasmapheresis is costly enough, which is expected to hamper the growth of the market.

Global therapeutic plasma exchange market is segmented on the basis of technique, indication, gender, end use and region. Indication segment is further divided into neurological disorders, renal disorders, hematology disorders, metabolic disorders, out of which, neurological disorders is expected to be the most dominant segment as the number of cases of chronic and fatal neurological disorders are increasing day by day.

North America held the largest market share in the year of 2019 due to the pre-existing pharma & biotech companies and the surge in research and development activities in the region. On the other hand, Asia-Pacific is expected to be the fastest growing region as the leading companies of therapeutic plasma exchange in the region have now started investing in the plasmapheresis procedures.

Haemonetics Corporation, Fresenius Medical Care, Terumo BCT, Inc., Baxter International Inc., Asahi Kasei Medical Co., Ltd., Kawasumi Laboratories Inc., B. Braun Melsungen AG, HemaCare Corporation, Medica S.p.A., Cerus Corporation, Nikkiso Co., Ltd., Miltenyi Biotec, Therakos Incorporation, Fenwal Incorporation, Kaneka Corporation, etc., are some of the prominent therapeutic plasma exchange companies of the world. To maintain their position in the global therapeutic plasma exchange market, the leading players are adopting several organic and inorganic strategies such as mergers, acquisitions, etc.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and estimate the market size of global therapeutic plasma exchange market from 2015 to 2018.
  • To estimate and forecast the market size of global therapeutic plasma exchange market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global therapeutic plasma exchange market based on technique, indication, gender, end use, company and region.
  • To identify dominant region or segment in the global therapeutic plasma exchange market.
  • To identify drivers and challenges for global therapeutic plasma exchange market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global therapeutic plasma exchange market.
  • To conduct pricing analysis for global therapeutic plasma exchange market.
  • To identify and analyze the profile of leading players operating in global therapeutic plasma exchange market.
  • To identify key sustainable strategies adopted by market players in global therapeutic plasma exchange market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals and clinics using therapeutic plasma exchange techniques across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals and clinics using therapeutic plasma exchange techniques which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals and clinics using therapeutic plasma exchange techniques, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global therapeutic plasma exchange market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Hospitals, clinics, research organizations and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to therapeutic plasma exchange
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals and clinics using therapeutic plasma exchange techniques, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global therapeutic plasma exchange market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Technique:

Centrifugation

Membrane Separation

  • Market, By Indication:

Neurological Disorders

Renal Disorders

Hematology Disorders

Metabolic Disorders

  • Market, By Gender:

Male

Female

  • Market, By End Use:

Hospitals

Clinics

Others

  • Market, By Region:

Asia-Pacific

  • China
  • India
  • Australia
  • Japan
  • South Korea

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

North America

  • United States
  • Mexico
  • Canada

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global therapeutic plasma exchange market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

  • 4.1. Brand Awareness (Aided/Unaided)
  • 4.2. Product Awareness
  • 4.3. Customer Satisfaction Analysis
  • 4.4. Unmet Needs/Challenges

5. Global Therapeutic Plasma Exchange Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique (Centrifugation v/s Membrane Separation)
    • 5.2.2. By Indication (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders)
    • 5.2.3. By Gender (Male v/s Female)
    • 5.2.4. By End Use (Hospitals, Clinics, Others)
    • 5.2.5. By Company (2019)
    • 5.2.6. By Region
  • 5.3. Product Market Map

6. Asia-Pacific Therapeutic Plasma Exchange Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique
    • 6.2.2. By Indication
    • 6.2.3. By End Use
    • 6.2.4. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Therapeutic Plasma Exchange Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technique
        • 6.3.1.2.2. By Indication
        • 6.3.1.2.3. By End Use
    • 6.3.2. India Therapeutic Plasma Exchange Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technique
        • 6.3.2.2.2. By Indication
        • 6.3.2.2.3. By End Use
    • 6.3.3. Australia Therapeutic Plasma Exchange Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technique
        • 6.3.3.2.2. By Indication
        • 6.3.3.2.3. By End Use
    • 6.3.4. Japan Therapeutic Plasma Exchange Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Technique
        • 6.3.4.2.2. By Indication
        • 6.3.4.2.3. By End Use
    • 6.3.5. South Korea Therapeutic Plasma Exchange Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Technique
        • 6.3.5.2.2. By Indication
        • 6.3.5.2.3. By End Use

7. Europe Therapeutic Plasma Exchange Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By Indication
    • 7.2.3. By End Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Therapeutic Plasma Exchange Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technique
        • 7.3.1.2.2. By Indication
        • 7.3.1.2.3. By End Use
    • 7.3.2. Germany Therapeutic Plasma Exchange Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technique
        • 7.3.2.2.2. By Indication
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Therapeutic Plasma Exchange Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technique
        • 7.3.3.2.2. By Indication
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Therapeutic Plasma Exchange Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technique
        • 7.3.4.2.2. By Indication
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Therapeutic Plasma Exchange Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technique
        • 7.3.5.2.2. By Indication
        • 7.3.5.2.3. By End Use

8. North America Therapeutic Plasma Exchange Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By Indication
    • 8.2.3. By End Use
    • 8.2.4. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Therapeutic Plasma Exchange Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technique
        • 8.3.1.2.2. By Indication
        • 8.3.1.2.3. By End Use
    • 8.3.2. Mexico Therapeutic Plasma Exchange Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technique
        • 8.3.2.2.2. By Indication
        • 8.3.2.2.3. By End Use
    • 8.3.3. Canada Therapeutic Plasma Exchange Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technique
        • 8.3.3.2.2. By Indication
        • 8.3.3.2.3. By End Use

9. South America Therapeutic Plasma Exchange Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By Indication
    • 9.2.3. By End Use
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Therapeutic Plasma Exchange Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technique
        • 9.3.1.2.2. By Indication
        • 9.3.1.2.3. By End Use
    • 9.3.2. Argentina Therapeutic Plasma Exchange Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technique
        • 9.3.2.2.2. By Indication
        • 9.3.2.2.3. By End Use
    • 9.3.3. Colombia Therapeutic Plasma Exchange Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technique
        • 9.3.3.2.2. By Indication
        • 9.3.3.2.3. By End Use

10. Middle East and Africa Therapeutic Plasma Exchange Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technique
    • 10.2.2. By Indication
    • 10.2.3. By End Use
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Therapeutic Plasma Exchange Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technique
        • 10.3.1.2.2. By Indication
        • 10.3.1.2.3. By End Use
    • 10.3.2. Saudi Arabia Therapeutic Plasma Exchange Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technique
        • 10.3.2.2.2. By Indication
        • 10.3.2.2.3. By End Use
    • 10.3.3. UAE Therapeutic Plasma Exchange Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technique
        • 10.3.3.2.2. By Indication
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Haemonetics Corporation
  • 13.2. Fresenius Medical Care
  • 13.3. Terumo BCT, Inc.
  • 13.4. Baxter International Inc.
  • 13.5. Asahi Kasei Medical Co., Ltd.
  • 13.6. Kawasumi Laboratories Inc.
  • 13.7. B. Braun Melsungen AG
  • 13.8. HemaCare Corporation
  • 13.9. Medica S.p.A.
  • 13.10. Cerus Corporation
  • 13.11. Nikkiso Co., Ltd.
  • 13.12. Miltenyi Biotec
  • 13.13. Therakos Incorporation
  • 13.14. Fenwal Incorporation
  • 13.15. Kaneka Corporation

14. Strategic Recommendations

15. About Us & Disclaimer